Recently, PgR expression < 20 % has been associated with poor prognosis [36, 47, 48], and patients initially diagnosed with PgR+ breast cancer had a worse outcome if recurrence of disease was PgR− [49]. This evidence concerns the gene PGR and breast carcinoma.